News for CPhI

New import laws spur hopes for reduced trial start-up time in Ukraine

By Natalie Morrison

- Last updated on GMT

New import laws spur hopes for reduced trial start-up time in Ukraine
Ukraine hopes changes to import laws will help cut trial start-up time from six month to 45 days.

Business development director for Ukraine firm Clinical Trail Logistics (CTL) Aleksey Mykheev told CPhI attendees that importing clinical investigational products now involves just two or three documents. Three years ago, the standard was 10.

He told Outsourcing-Pharma.com: “The legal system is being actively modernised. In 2012 customs legislation was significantly simplified and unified with European laws. As a result the number of customs procedures was reduced.”

With the new possibility for an electronic submission, he added, the customs process is much simpler.

“The Ukraine regulatory authority is expecting start-up phase, including supply of initial investigational product sites will decrease to 45 days,”​ Mykheev added.

He also said that with the possibility of eliminated clinical logistics VAT on imports until 2013 because of further expected updates to customs procedure, the Ukraine is becoming an increasingly popular destination for clinical trials.

However

Mykheev said however a stumbling block for many sponsors and logistics firms is a lack of knowledge about a new requirement, which stipulates all suppliers must first sign an agreement with the local site before importing investigational product.

“It is very important for sponsors and logistics companies to know this,”​ he said.

He also said recent Ministry of Health (MoH) updates could delay the streamlines imports process significantly because it now requires written permission and a good manufacturing practice (GMP) certificate with each batch. Previously the documentation was only required per shipment.

When asked how expectations of 45-day start-up time can happen in the face of the new regulation, he admitted: “It’s difficult to say if it will happen because the updated regulations have only been affective for three months.”

He added however that the local industry remains positive, and continues to expect significant growth over the next five years.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars